Jia, B., Shi, Y., Kang, S., Yang, S., Hu, S., Li, Y., . . . He, X. (2015). Addition of rituximab is not associated with survival benefit compared with CHOP alone for patients with stage I diffuse large B-cell lymphoma. Chin J Cancer Res.
Stile di citazione ChicagoJia, Bo, et al. "Addition of Rituximab Is Not Associated With Survival Benefit Compared With CHOP Alone for Patients With Stage I Diffuse Large B-cell Lymphoma." Chin J Cancer Res 2015.
Citazione MLAJia, Bo, et al. "Addition of Rituximab Is Not Associated With Survival Benefit Compared With CHOP Alone for Patients With Stage I Diffuse Large B-cell Lymphoma." Chin J Cancer Res 2015.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.